Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 1-DAY-TRADERS on MOMENTUM - Short & Long Stock picks -- Ignore unavailable to you. Want to Upgrade?

To: Sheri who wrote (340)	10/22/1998 8:20:00 AM
From: Candle stick	Respond to of 537

Have a look at CLTR, biotech with cancer drug news out today. Should jump> Thursday October 22, 3:05 am Eastern Time Coulter reports positive results of lymphoma drug "The drug is made by adding the radiation factor, Iodine-131 to the Anti-B1 antibody. The antibody recognizes the cancer cells and the Iodine attached to the cell radiates and kills the cells. Other drugs being developed take a similar approach but Bexxar is the closest to seeking approval from regulators. biz.yahoo.com Another ENMD????